The European Commission has launched a public consultation on the revision of EU pharmaceutical legislation, to respond to the crisis and to provide adequate responses to the health needs of the population. This is a new step towards the ambitious reform announced in the Pharmaceutical Strategy for Europe adopted in November 2020.
The public consultation concerns in particular the effectiveness of EU pharmaceutical legislation, unmet medical needs, incentives for innovation, antimicrobial resistance, adaptation to future needs of the regulatory framework for new products, better access to medicines, the competitiveness of European markets to ensure affordable medicines, the repositioning of medicines, the supply, the quality and manufacture of medicines, environmental challenges.
"Today we are taking an important step which will lead us, by the end of next year, to a reform of EU pharmaceutical legislation. An updated regulatory framework for pharmaceutical products is an essential prerequisite for a European Union. I invite all citizens and stakeholders to help us shape EU rules for the future that meet patients' needs and preserve the ability to innovation and the global competitiveness of our industry ”said Stella Kyriakides, Commissioner for Health and Food Safety.